More possibilities for renewed relief.
We’re developing Nervida to give people living with chronic back pain the possibility of renewed relief.
In preclinical development. Not yet available for treatment.
More room for life.
For patients, the ambition is less disruption from repeat procedures and more freedom to plan everyday life.
More possibilities for care.
For physicians, it is another potential option for addressing recurring pain and supporting patients over time.
These needs guide the development of Nervida.
Starting with chronic back pain.
Our initial focus is people whose chronic back pain returns after treatment. Their need for renewed relief guides the questions we ask and the care we aspire to make possible.
Our vision extends to other chronic pain conditions, while our development efforts begin with chronic back pain.
A vision guided by science.
Creating more possibilities in pain care takes careful research. Our work is guided by the needs of patients and physicians, with safety and meaningful relief as the questions that matter.
Nervida remains in preclinical development. Its safety and effectiveness have not yet been established, and it is not available for treatment.
Receive email updates on Nervida, our research, and company news.